Mike Matson
Stock Analyst at Needham
(2.42)
# 2,355
Out of 4,840 analysts
529
Total ratings
42.96%
Success rate
-1.3%
Average return
Main Sectors:
Stocks Rated by Mike Matson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HOLX Hologic | Reiterates: Hold | n/a | $64.30 | - | 21 | May 28, 2025 | |
| INGN Inogen | Upgrades: Buy | $12 | $6.55 | +83.21% | 19 | May 22, 2025 | |
| MDT Medtronic | Reiterates: Hold | n/a | $81.78 | - | 19 | May 22, 2025 | |
| MMSI Merit Medical Systems | Reiterates: Buy | $108 | $94.78 | +13.95% | 28 | May 20, 2025 | |
| LUCD Lucid Diagnostics | Reiterates: Buy | $3 | $1.49 | +101.34% | 19 | May 14, 2025 | |
| ESTA Establishment Labs Holdings | Upgrades: Buy | $48 | $36.34 | +32.09% | 2 | May 14, 2025 | |
| LIVN LivaNova | Reiterates: Buy | $64 | $43.17 | +48.25% | 26 | May 13, 2025 | |
| OCX OncoCyte | Reiterates: Buy | $4.25 | $3.32 | +28.01% | 18 | May 13, 2025 | |
| ENOV Enovis | Maintains: Buy | $64 → $57 | $33.01 | +72.67% | 15 | May 9, 2025 | |
| HAE Haemonetics | Maintains: Buy | $104 → $84 | $66.97 | +25.43% | 13 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $42 | $20.75 | +102.46% | 23 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $51 → $41 | $26.95 | +52.13% | 17 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $32 | $29.08 | +10.04% | 17 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $91 → $61 | $57.34 | +6.39% | 24 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $29.00 | - | 21 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $51 → $44 | $33.67 | +30.68% | 34 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $8.5 | $7.35 | +15.65% | 25 | Apr 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $14.52 | - | 19 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $113 → $115 | $105.09 | +9.43% | 29 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $128.56 | - | 9 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $156.55 | - | 25 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $4.78 | +46.44% | 20 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $128.92 | - | 5 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $244.60 | - | 11 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $442 | $381.52 | +15.85% | 8 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $122.20 | - | 9 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $263.83 | - | 10 | Feb 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $93.08 | - | 26 | Feb 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $245.70 | - | 14 | Jan 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $42 | $18.37 | +128.63% | 2 | May 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $65 → $75 | $59.37 | +26.33% | 1 | Feb 18, 2021 |
Hologic
May 28, 2025
Reiterates: Hold
Price Target: n/a
Current: $64.30
Upside: -
Inogen
May 22, 2025
Upgrades: Buy
Price Target: $12
Current: $6.55
Upside: +83.21%
Medtronic
May 22, 2025
Reiterates: Hold
Price Target: n/a
Current: $81.78
Upside: -
Merit Medical Systems
May 20, 2025
Reiterates: Buy
Price Target: $108
Current: $94.78
Upside: +13.95%
Lucid Diagnostics
May 14, 2025
Reiterates: Buy
Price Target: $3
Current: $1.49
Upside: +101.34%
Establishment Labs Holdings
May 14, 2025
Upgrades: Buy
Price Target: $48
Current: $36.34
Upside: +32.09%
LivaNova
May 13, 2025
Reiterates: Buy
Price Target: $64
Current: $43.17
Upside: +48.25%
OncoCyte
May 13, 2025
Reiterates: Buy
Price Target: $4.25
Current: $3.32
Upside: +28.01%
Enovis
May 9, 2025
Maintains: Buy
Price Target: $64 → $57
Current: $33.01
Upside: +72.67%
Haemonetics
May 8, 2025
Maintains: Buy
Price Target: $104 → $84
Current: $66.97
Upside: +25.43%
May 8, 2025
Reiterates: Buy
Price Target: $42
Current: $20.75
Upside: +102.46%
May 8, 2025
Maintains: Buy
Price Target: $51 → $41
Current: $26.95
Upside: +52.13%
May 6, 2025
Reiterates: Buy
Price Target: $32
Current: $29.08
Upside: +10.04%
May 1, 2025
Maintains: Buy
Price Target: $91 → $61
Current: $57.34
Upside: +6.39%
Apr 30, 2025
Reiterates: Hold
Price Target: n/a
Current: $29.00
Upside: -
Apr 30, 2025
Maintains: Buy
Price Target: $51 → $44
Current: $33.67
Upside: +30.68%
Apr 29, 2025
Maintains: Buy
Price Target: $18 → $8.5
Current: $7.35
Upside: +15.65%
Apr 28, 2025
Reiterates: Hold
Price Target: n/a
Current: $14.52
Upside: -
Apr 24, 2025
Maintains: Buy
Price Target: $113 → $115
Current: $105.09
Upside: +9.43%
Apr 23, 2025
Reiterates: Hold
Price Target: n/a
Current: $128.56
Upside: -
Apr 10, 2025
Reiterates: Hold
Price Target: n/a
Current: $156.55
Upside: -
Apr 10, 2025
Reiterates: Buy
Price Target: $7
Current: $4.78
Upside: +46.44%
Apr 8, 2025
Reiterates: Hold
Price Target: n/a
Current: $128.92
Upside: -
Apr 7, 2025
Reiterates: Hold
Price Target: n/a
Current: $244.60
Upside: -
Mar 21, 2025
Reiterates: Buy
Price Target: $442
Current: $381.52
Upside: +15.85%
Mar 12, 2025
Reiterates: Hold
Price Target: n/a
Current: $122.20
Upside: -
Feb 19, 2025
Reiterates: Hold
Price Target: n/a
Current: $263.83
Upside: -
Feb 7, 2025
Reiterates: Hold
Price Target: n/a
Current: $93.08
Upside: -
Jan 31, 2025
Reiterates: Hold
Price Target: n/a
Current: $245.70
Upside: -
May 4, 2021
Maintains: Buy
Price Target: $34 → $42
Current: $18.37
Upside: +128.63%
Feb 18, 2021
Maintains: Buy
Price Target: $65 → $75
Current: $59.37
Upside: +26.33%